• Kristiansen Snyder posted an update 5 hours, 57 minutes ago

    The visualization of glycogen deposits in cells and tissues is important for studying glycogen metabolism as well as diagnosis of glycogen storage diseases. Evidence suggests that the demonstration of glycogen can better be enhanced by factors such the choice of fixative and temperature during fixation. Here, we assessed efficacy of neutral buffered formalin (NBF), alcoholic formalin (AF) and paraformaldehyde (PFA) at 4 °C, 37 °C and 40 °C using Periodic Acid Schiff’s staining method. Each liver specimen was fixed in NBF and AF while the brain tissues were fixed in NBF, AF and PFA. We found that there was a better PAS staining intensity with the liver tissues fixed in AF compared with NBF. Also, there was no difference in the quality of the staining for tissues fixed in AF at 37 °C, 4 °C and 40 °C, but fixation with NBF at 4 °C gave the best staining quality when compared with 40 °C and 37 °C. Furthermore, hippocampal tissues fixed in AF showed better quality of PAS staining compared with NBF and PFA. A significant increase in staining intensity was observed for PFA when compared with NBF. Superior staining intensity for PAS was observed at 4 °C for hippocampal tissues fixed with NBF, AF and PFA. Taken together our results show that AF at a temperature of 4 °C gave the best result. Hence, glycogen demonstration can better be enhanced by the choice of fixative and temperature during fixation.Cerebral palsy (CP) is a serious disorder that has serious consequences on the functioning of children and their families. This study explores family functioning (adaptation, cohesion and family type) and strengths (pride, accord and whole) in Greek and Italian families raising a child with CP and their interaction. Participants were 120 parents of a biological child with CP. Data collection used a self-report questionnaire, the Family Adaptability and Cohesion Evaluation Scale (FACES-III) and the Family Strengths Inventory. According to the findings, parents (in both countries) estimate and wish their family to be in the balanced range which represents healthy family functioning according to the revised edition of the Olson Circumplex Model. Finally, they share a high sense of family strengths, which is mainly displayed in the high sense of pride and accord.This study investigated the feasibility of polysaccharide-coated poly(n-butyl cyanoacrylate) (PBCA) nanoparticles for oral delivery of acyclovir (ACV). PBCA nanoparticles were obtained by the emulsion polymerization method. Chitosan was chemically modified to obtain N,N,N-trimethylchitosan (TMC), which was used to coat the nanoparticles (PBCA-TMC). Nanoparticles were characterized by dynamic light scattering, zeta potential, differential scanning calorimetry (DSC), atomic force microscopy (AFM), cytotoxicity, and the effect on the transepithelial electrical resistance (TEER) of the Caco-2 cells. The size of the coated nanoparticles (296.2 nm) was significantly larger than uncoated (175.0 nm). Furthermore, PBCA nanoparticles had a negative charge (-11.7 mV), which was inverted to highly positive values (+36.5 mV) after coating. DSC analysis suggested the occurrence of the coating, which was confirmed by AFM images. The MTT assay revealed concentration-dependent cytotoxicity for the core-shell nanoparticles. Additionally, PBCA-TMC caused a significant but reversible decrease in the Caco-2 cell monolayer TEER. Entrapped ACV (PBCA-ACV-TMC), a Biopharmaceutical Classification System class III drug substance, increased approximately 3.25 times the Papp of ACV in the Caco-2 permeability assay. The nanoparticles were also able to provide in vitro ACV controlled release using media with different pH values (1.2; 6.8; 7.4). Accordingly, this new core-shell nanoparticle showed the potential to improve the oral delivery of ACV.Electrochemical biointerfaces are constructed with a wide range of nanomaterials and conducting polymers that strongly affect the analytical performance of biosensors. The analysis of progress toward electrochemical sensing platforms offers opportunities to provide devices for commercial use. The investigation of different methods for the synthesis of phenol biointerfaces leads to design challenges in the field of monitoring phenolic compounds. This paper review the innovative strategies and feature techniques in the construction of phenolic compound biosensors. The focus was made on the preparation methods of nanostructures and nanomaterials design for catalytic improvements of sensing interfaces. The paper also provides a comprehensive overview in the field of enzyme immobilization approaches at solid supports and technical formation of polymer nanocomposites, as well as applications of hybrid organic-inorganic nanocomposites in phenolic biosensors. This review also highlights the recent progress in the electrochemical detection of phenolic compounds and summarizes analytical performance parameters including sensitivity, storage stability, limit of detection, linear range, and Michaelis-Menten kinetic analysis. It also emphasizes advances from the past decade including technical challenges for the construction of suitable biointerfaces for monitoring phenolic compounds.COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug repurposing has been employed to rapidly find a cure; but despite great efforts, no drug or vaccine is presently available for treating or prevention of COVID-19. KRX-0401 Apart from antivirals, immunotherapeutic strategies are suggested considering the role of the immune response as the host defense against the virus, and the fact that SARS-CoV-2 suppresses interferon induction as an immune evasion strategy. Active immunization through vaccines, interferon administration, passive immunotherapy by convalescent plasma or synthesized monoclonal and polyclonal antibodies, as well as immunomodulatory drugs, are different immunotherapeutic approaches that will be mentioned in this review. The focus would be on passive immunotherapeutic interventions. Interferons might be helpful in some stages. Vaccine development has been followed with unprecedented speed.